One platform. Three tiers.

All data is sourced from publicly available FDA databases, including the 510(k) clearance database, De Novo decisions, guidance document repository, warning letter database, and MAUDE adverse event reports. AIFDA Intel does not use licensed, proprietary, or non-public data sources.

Data is synced daily from FDA's public databases. Each data page displays a "last synced" timestamp. FDA's own publication timelines mean some records may not appear immediately after FDA action. Always verify directly at FDA.gov for time-sensitive regulatory decisions.

No. AIFDA Intel is a research and intelligence tool. It summarizes and organizes public FDA records. Nothing on this platform constitutes regulatory advice, legal counsel, or a prediction of FDA clearance outcomes. For regulatory strategy or legal questions, consult a qualified regulatory affairs professional or attorney.

Yes. AIFDA Intel does not store, process, or display patient health information. All data is device-level and company-level public regulatory records. No Business Associate Agreement (BAA) is required.

All account and application data is stored on SOC 2 Type II certified infrastructure. Data is encrypted at rest and in transit. We do not store payment card details — all billing is processed by Stripe. Full details are in our Privacy Policy.

Yes. All plans are monthly. Cancel anytime from your account settings. Your access continues until the end of the current billing period.